Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Director departure

Armata Pharmaceuticals, Inc. (APHB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update"
03/16/2023 8-K Quarterly results
11/09/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
08/12/2021 8-K Quarterly results
Docs: "Armata Pharmaceuticals Announces Second Quarter Results and Provides General Corporate Update"
05/14/2021 8-K Quarterly results
03/19/2020 8-K Quarterly results
Docs: "Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Results and Provides General Corporate Update MARINA DEL REY, Calif., March 19, 2020 -- Armata Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced results for the fourth quarter and full year 2019 and provided a corporate and clinical update. Key Fourth Quarter and Subsequent Period Highlights:"
08/09/2018 8-K Quarterly results
Docs: "AmpliPhi Biosciences Reports Second Quarter 2018 Financial Results and Business Highlights"
05/15/2018 8-K Quarterly results
Docs: "AmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business Highlights",
"Corporate Presentation"
03/14/2018 8-K Quarterly results
Docs: "AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2017 Financial Results and Business Highlights"
11/14/2017 8-K Quarterly results
Docs: "AmpliPhi Biosciences Reports Third Quarter 2017 Financial Results and Business Highlights"
08/14/2017 8-K Quarterly results
05/15/2017 8-K Quarterly results
Docs: "AmpliPhi Biosciences Reports First Quarter 2017 Financial Results and Provides Business Highlights"
08/15/2016 8-K Quarterly results
Docs: "AmpliPhi Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update"
03/31/2016 8-K Quarterly results
Docs: "AmpliPhi Biosciences Reports Full-Year 2015 Financial Results",
"Excerpt of transcript from conference call held on March 30, 2016 relating to financial results"
11/16/2009 8-K Quarterly results
Docs: "TARGETED GENETICS CORPORATION REPORTS THIRD QUARTER 2009 FINANCIAL RESULTS"
08/12/2009 8-K Quarterly results
Docs: "TARGETED GENETICS CORPORATION REPORTS SECOND QUARTER 2009 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES"
05/07/2009 8-K Quarterly results
Docs: "TARGETED GENETICS CORPORATION REPORTS FIRST QUARTER 2009 FINANCIAL"
03/31/2009 8-K Form 8-K -- Current report
11/06/2008 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS THIRD QUARTER 2008 FINANCIAL RESULTS"
08/07/2008 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS SECOND QUARTER 2008 FINANCIAL RESULTS"
05/12/2008 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS FIRST QUARTER 2008 FINANCIAL RESULTS"
03/28/2008 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS FOURTH QUARTER AND YEAR-END 2007 FINANCIAL RESULTS"
11/05/2007 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS THIRD QUARTER 2007 FINANCIAL RESULTS"
08/10/2007 8-K Quarterly results
Docs: "Investor and Media Contact:"
05/09/2007 8-K Quarterly results
Docs: "®"
03/29/2007 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS FOURTH QUARTER AND YEAR-END 2006 FINANCIAL RESULTS"
11/08/2006 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS THIRD QUARTER 2006 FINANCIAL RESULTS"
05/02/2006 8-K Quarterly results
Docs: "Investor and Media Contact:"
07/28/2005 8-K Quarterly results
Docs: "Investor and Media Contact:"
04/26/2005 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS FIRST QUARTER 2005 FINANCIAL RESULTS"
03/03/2005 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS FOURTH QUARTER AND YEAR-END 2004 FINANCIAL RESULTS"
11/04/2004 8-K Quarterly results
Docs: "TARGETED GENETICS REPORTS THIRD QUARTER 2004 FINANCIAL RESULTS"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy